Alumis (ALMS) Share-based Compensation (2023 - 2025)
Alumis' (ALMS) quarterly Share-based Compensation came in at -$236.3 million in Q4 2025, down 3816.59% year-on-year from $6.4 million in Q4 2024, and down 458.03% on a QoQ basis from $66.0 million in Q3 2025.
Alumis (ALMS) Share-based Compensation (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Share-based Compensation data on file, last reported at -$236.3 million in Q4 2025.
- On a quarterly basis, Share-based Compensation fell 3816.59% year-over-year to -$236.3 million in Q4 2025; TTM through Dec 2025 was -$219.5 million, a 1228.13% decrease from a year earlier, with the FY2025 full-year figure at $60.0 million, up 10.29% from the prior year.
- Share-based Compensation for Q4 2025 stood at -$236.3 million, down from $66.0 million in the prior quarter.
- Over the last five years, Share-based Compensation for ALMS reached as high as $66.0 million in Q3 2025 and fell as low as -$236.3 million in Q4 2025.
- Historically, Share-based Compensation has averaged -$1.7 million across 3 years, with a median of $3.1 million in 2024.
- On a YoY basis, Share-based Compensation climbed as much as 2274.86% in 2025 and fell as far as 3816.59% in 2025.
- Year by year, Share-based Compensation stood at $2.6 million in 2023, then soared by 143.14% to $6.4 million in 2024, then sank by 3816.59% to -$236.3 million in 2025.
- Per Business Quant data, the three most recent Share-based Compensation figures were -$236.3 million in Q4 2025, $66.0 million in Q3 2025, and $62.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | -236.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -236.30 Mn |
| Dec 31, 2025 | -236.30 Mn |
| Sep 30, 2025 | 66.00 Mn |
| Sep 30, 2025 | 66.00 Mn |
| Jun 30, 2025 | 62.00 Mn |
| Jun 30, 2025 | 62.00 Mn |
| Mar 31, 2025 | 63.10 Mn |
| Mar 31, 2025 | 63.10 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 3.13 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Sep 30, 2023 | 2.27 Mn |